Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that the patient began to experience apnea and vns parameters were reduced.The patient later followed up for the apnea and settings were increased.Since the follow-up, the patient was admitted to the hospital due to heart valve blockage and vns parameters were reduced; the physicians later proposed implanting a pacemaker.Prior to the pacemaker implant, the vns was disabled and patient was monitored.During stimulation the patient's heart rate (hr) was seen at 120 bpm and with the vns disabled the hr dropped to 90 bpm.Session reports were provided and diagnostics were all seen within normal visits.Update was received that the vns remains off and the hr has dropped from 120 bpm to 80 - 100 bmp.The physicians suspect that the high dosage from the vns could be the cause from the event.The vns will remain off and patient will have a pacemaker implanted.The plan is to increase the output to 0.25 ma and monitor the patient.Response was received from the physician.The physician noted that the patient presented with syncope initially and had no history of cardiac events.The hr prior to event was 80-120 bpm and the hr during event 0-30 bpm.Per the physician, the arrhythmia was possibly related to the vns.The patient also had a pacemaker implanted and has experienced no arrhythmia since the implant.No other relevant information has been received to date.
|